Bringhen, S., Cani, L., Giuliani, N., Mangiacavalli, S., Benevolo, G., Antonioli, E., . . . Larocca, A. (2025). Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: The Real MM phase IV trial. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationBringhen, Sara, et al. Bortezomib-melphalan-prednisone Versus Lenalidomide-dexamethasone in Elderly Patients with Multiple Myeloma: The Real MM Phase IV Trial. Ferrata Storti Foundation, 2025.
MLA (9th ed.) CitationBringhen, Sara, et al. Bortezomib-melphalan-prednisone Versus Lenalidomide-dexamethasone in Elderly Patients with Multiple Myeloma: The Real MM Phase IV Trial. Ferrata Storti Foundation, 2025.
Warning: These citations may not always be 100% accurate.